Skip to search formSkip to main contentSkip to account menu

Immunoconjugates

Known as: Icon, Immunoconjugate, Immunoconjugates [Chemical/Ingredient] 
Combinations of diagnostic or therapeutic substances linked with specific immune substances such as IMMUNOGLOBULINS; MONOCLONAL ANTIBODIES; or… 
National Institutes of Health

Related topics

Related topics

40 relations

Narrower (30)

AGS67EAMG 595ANG4043D2C7-(scdsFv)-PE38KDEL

Broader (2)

AntibodiesImmunologic Factors
BRENTUXIMABBispecific CD19-directed CD3-directed T Cell Engager [EPC]ImmunotherapyImmunotoxicity

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Field Trial Tests On The Efficacy And Residual Effects Of Bistar® 10wp On Mosquitoes And Other Household Arthropod Pests
A field test on the efficacy and residual effect of Bistar® 10WP on mosquitoes and other household arthropod pests was conducted… 
2007
2007
Comparison of two anthracycline-based prodrugs for activation by a monoclonal antibody-β-glucuronidase conjugate in the specific treatment of cancer
Antibody-directed enzyme prodrug therapy (ADEPT) may improve the therapeutic index of cytostatic agents. We compared two prodrugs… 
2007
2007
[Antitumor activities of various immunoconjugates composed of lidamycin and anti-type IV collagenase monoclonal antibody].
This study is to investigate the antitumor activities of the immunoconjugates composed of anti-type IV collagenase monoclonal… 
2004
2004
Preparation of immunoconjugates using antibody oligosaccharide moieties.
  • C. Vogel
  • Methods in molecular biology
  • 2004
  • Corpus ID: 21382469
Heterobifunctional crosslinking reagents are small molecular weight chemicals containing two different reactive groups that have… 
2001
2001
Technology evaluation: C242-DM1, ImmunoGen Inc.
  • S. Smith
  • Current opinion in molecular therapeutics (Print)
  • 2001
  • Corpus ID: 22143103
C242-DM1 is a tumor-activated immunotoxin under development by GlaxoSmithKline plc (formerly SmithKline Beecham plc), under… 
1997
1997
Idarubicin-anti-CD3: a new immunoconjugate that induces alloantigen-specific tolerance in mice.
BACKGROUND In testing new anti-CD3 agents for transplantation tolerance induction, an anti-CD3 monoclonal antibody was used as a… 
1994
1994
RESIDUAL EFFECT OF LAMBDACYHALOTHRIN (ICON 10% WP) ON DIFFERENT SURFACES IN SOUTH OF IRAN
An investigation was made to study the residual activity and air-borne effect of lambdacyhalothrin (Icon 10 WP) at 30, 40 and 50… 
1992
1992
Thrombolytic and pharmacokinetic properties of an immunoconjugate of single-chain urokinase-type plasminogen activator (u-PA) and a bispecific monoclonal antibody against fibrin and against u-PA in…
Targeting of plasminogen activators to the fibrin component of a thrombus with the use of monoclonal antibodies (MA) directed… 
1991
1991
Custom-tailored drug immunoconjugates in cancer therapy.
: Forty-three patients with disseminated refractory malignancies each received an individually specified combination of either… 
Review
1988
Review
1988
Immunotoxins containing single-chain ribosome-inactivating proteins.
We have summarized what is currently known about the distribution, biological role, and the mechanism of action of the single…